ID   SaOS-LM2
AC   CVCL_9564
SY   SAOS-LM2; SaOSLM2
DR   KCLB; 80024
DR   Wikidata; Q54952104
RX   PubMed=10763916;
CC   Population: Caucasian.
CC   Doubling time: 43.6 +- 4.2 hours (PubMed=10763916).
CC   Sequence variation: Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): KCLB=80024
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 8,10
ST   FGA: 22,25
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9563 ! SaOS-LM1
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 18
//
RX   PubMed=10763916; DOI=10.1023/A:1006623001465;
RA   Jia S.-F., Worth L.L., Kleinerman E.S.;
RT   "A nude mouse model of human osteosarcoma lung metastases for
RT   evaluating new therapeutic strategies.";
RL   Clin. Exp. Metastasis 17:501-506(1999).
//